Coronary artery disease is associated with increased lipoprotein(a) concentrations independent of the size of circulating apolipoprotein(a) isoforms.

Coronary artery disease is associated with increased lipoprotein(a) concentrations independent of the size of circulating apolipoprotein(a) isoforms.

Lipoprotein(a) [Lp(a)] concentration and apolipoprotein(a) [apo(a)] isoforms (identified by sodium dodecyl sulfate-polyacrylamide gel electrophoresis [SDS-PAGE] and Western blotting) were determined in a group of 508 asymptomatic Caucasian members of the community and in 318 Caucasian patients with...

Bibliografiset tiedot
Päätekijät:	Farrer, M, Game, F, Albers, C, Neil, H, Winocour, P, Laker, M, Adams, P, Alberti, K
Aineistotyyppi:	Journal article
Kieli:	English
Julkaistu:	1994

Samankaltaisia teoksia

Association between impaired glucose tolerance and circulating concentration of Lp(a) lipoprotein in relation to coronary heart disease.
Tekijä: Farrer, M, et al.
Julkaistu: (1993)

Simvastatin in non-insulin-dependent diabetes mellitus: effect on serum lipids, lipoproteins and haemostatic measures.
Tekijä: Farrer, M, et al.
Julkaistu: (1994)

Impact of lipoprotein(a) levels and apolipoprotein(a) isoform size on risk of coronary heart disease
Tekijä: Hopewell, J, et al.
Julkaistu: (2014)

Impact of lipoprotein(a) levels and apolipoprotein(a) isoform size on risk of coronary heart disease.
Tekijä: Hopewell, J, et al.
Julkaistu: (2014)

Relation between insulinemia, body mass index, and lipoprotein composition in healthy, nondiabetic men and women.
Tekijä: Winocour, P, et al.
Julkaistu: (1992)

High apolipoprotein AI concentrations are associated with lower mortality and myocardial infarction five years after coronary artery bypass graft surgery.
Tekijä: Skinner, J, et al.
Julkaistu: (1999)

Impact of apolipoprotein(a) isoform size on lipoprotein(a) lowering in the HPS2-THRIVE study
Tekijä: Parish, S, et al.
Julkaistu: (2018)

Relationship of apolipoprotein(a) isoform size with clearance and production of lipoprotein(a) in a diverse cohort
Tekijä: Anastasiya Matveyenko, et al.
Julkaistu: (2023-03-01)

Serum Lp(a) lipoprotein concentration is not associated with clinical and angiographic outcome five years after coronary artery bypass graft surgery.
Tekijä: Skinner, J, et al.
Julkaistu: (1997)

Assessing the impact of blood sample type on the estimated prevalence of impaired glucose tolerance and diabetes mellitus in epidemiological surveys.
Tekijä: Farrer, M, et al.
Julkaistu: (1995)

Association of Apolipoprotein(a) Isoforms With Coronary Heart Disease is Mediated Through Plasma Lipoprotein(a) Levels
Tekijä: Hopewell, J, et al.
Julkaistu: (2010)

Lipoprotein(a) Particle Production as a Determinant of Plasma Lipoprotein(a) Concentration Across Varying Apolipoprotein(a) Isoform Sizes and Background Cholesterol‐Lowering Therapy
Tekijä: Dick C. Chan, et al.
Julkaistu: (2019-04-01)

Lipoprotein(a) levels, apo(a) isoform size, and coronary heart disease risk in the Framingham Offspring Study
Tekijä: Stefania Lamon-Fava, et al.
Julkaistu: (2011-06-01)

An altered pattern of circulating apolipoprotein E3 isoforms is implicated in preeclampsia
Tekijä: Kelly R. Atkinson, et al.
Julkaistu: (2009-01-01)

Patients undergoing coronary artery bypass graft surgery are at high risk of impaired glucose tolerance and diabetes mellitus during the first postoperative year.
Tekijä: Farrer, M, et al.
Julkaistu: (1995)

Treatment effects on serum lipoprotein lipids, apolipoproteins and low density lipoprotein particle size and relationships of lipoprotein variables to progression of coronary artery disease in the Bezafibrate Coronary Atherosclerosis Intervention Trial (BECAIT).
Tekijä: Ruotolo, G, et al.
Julkaistu: (1998)

Application of osmometric methods to the study of lipids, lipoproteins, and apolipoproteins.
Tekijä: E T Adams, Jr
Julkaistu: (1990-05-01)

Patient-related outcomes five years after coronary artery bypass graft surgery.
Tekijä: Skinner, J, et al.
Julkaistu: (1999)

Lipoprotein (a) and apolipoprotein BD100 in coronary heart disease pathogenesis
Tekijä: K. I. Tebloev, et al.
Julkaistu: (2005-10-01)

Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: A multivariable Mendelian randomisation analysis.
Tekijä: Tom G Richardson, et al.
Julkaistu: (2020-03-01)

Lipoprotein(a), its autoantibodies, and circulating T lymphocyte subpopulations as independent risk factors for coronary artery atherosclerosis
Tekijä: O I Afanasievа, et al.
Julkaistu: (2016-09-01)

The Association Between Small Dense Low Density Lipoprotein,Apolipoprotein B, Apolipoprotein B/apolipoprotein A1 Ratio and coronary Artery Stenosis
Tekijä: Abbas Zavarehee, et al.
Julkaistu: (2009-05-01)

Rat plasma lipoproteins and apolipoproteins in experimental hypothyroidism.
Tekijä: L Dory, et al.
Julkaistu: (1981-02-01)

Development and validation of an isoform-independent monoclonal antibody–based ELISA for measurement of lipoprotein(a)
Tekijä: Santica M. Marcovina, et al.
Julkaistu: (2022-08-01)

The ratio of low-density lipoprotein cholesterol to apolipoprotein-B as a marker of low-density lipoprotein particle size
Tekijä: A. M. Kaneva, et al.
Julkaistu: (2018-06-01)

Small size apolipoprotein(a) isoforms enhance inflammatory and proteolytic potential of collagen-primed monocytes
Tekijä: Nadia Sabbah, et al.
Julkaistu: (2019-08-01)

Clinical outcome measures eight years following Coronary Artery Bypass Grafting (CABG): A prospective cohort study
Tekijä: Mackin, P, et al.
Julkaistu: (1999)

High frequency of mutations in the human lipoprotein lipase gene in pregnancy-induced chylomicronemia: possible association with apolipoprotein E2 isoform.
Tekijä: Y Ma, et al.
Julkaistu: (1994-06-01)

Lipoprotein, apolipoprotein, and lipolytic enzyme changes following estrogen administration in postmenopausal women.
Tekijä: D Applebaum-Bowden, et al.
Julkaistu: (1989-12-01)

SPECIFICS OF SUBFRACTIONAL SPECTRUM OF APOLIPOPROTEIN B RELATED LIPOPROTEINES IN CAROTID OR CORONARY ATHEROSCLEROSIS PATIENTS
Tekijä: N. E. Gavrilova, et al.
Julkaistu: (2016-10-01)

Relationship between Apolipoprotein E Genotype and Lipoprotein Profile in Patients with Coronary Heart Disease
Tekijä: Yahui Lin, et al.
Julkaistu: (2022-02-01)

Comparison of apolipoprotein B to cholesterol in low density lipoproteins of patients with coronary heart disease.
Tekijä: G L Vega, et al.
Julkaistu: (1984-06-01)

Lipoprotein(a) and the Apolipoprotein B/A1 Ratio Independently Associate With Surgery for Aortic Stenosis Only in Patients With Concomitant Coronary Artery Disease
Tekijä: Johan Ljungberg, et al.
Julkaistu: (2017-12-01)

Independent regulation of plasma apolipoprotein C-II and C-III concentrations in very low density and high density lipoproteins: implications for the regulation of the catabolism of these lipoproteins.
Tekijä: N A Le, et al.
Julkaistu: (1988-05-01)

Identification of apolipoprotein B-100 low density lipoproteins, apolipoprotein B-48 remnants, and apolipoprotein E-rich high density lipoproteins in the mouse.
Tekijä: H V de Silva, et al.
Julkaistu: (1994-07-01)

The functions of apolipoproteins and lipoproteins in health and disease
Tekijä: Zijun Ma, et al.
Julkaistu: (2024-10-01)

Plasma lipoproteins: apolipoprotein structure and function.
Tekijä: R W Mahley, et al.
Julkaistu: (1984-12-01)

Turkish Heart Study: lipids, lipoproteins, and apolipoproteins.
Tekijä: R W Mahley, et al.
Julkaistu: (1995-04-01)

Clusterin/apolipoprotein J, its isoforms and Alzheimer's disease
Tekijä: Giedre Milinkeviciute, et al.
Julkaistu: (2023-04-01)

Prevention of low density lipoprotein aggregation by high density lipoprotein or apolipoprotein A-I.
Tekijä: JC Khoo, et al.
Julkaistu: (1990-04-01)